No abstract available
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Benzamides
-
Clinical Trials as Topic
-
Cytarabine / administration & dosage
-
Humans
-
Imatinib Mesylate
-
Interferon-alpha / administration & dosage
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Multicenter Studies as Topic
-
Piperazines / pharmacology*
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyrimidines / pharmacology*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Interferon-alpha
-
Piperazines
-
Pyrimidines
-
Cytarabine
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases